Coxsackie Nosode A3, A4, A5, A7, B1, B3, B5
Over-the-Counter상품명: HFM CORD
About This Medication
Oral preparation used for symptom management and health support.
유효 성분
| 성분 | 함량 |
|---|---|
| Human Coxsackievirus A | - |
| Human Coxsackievirus A7 | - |
| Human Coxsackievirus B | - |
| Human Coxsackievirus B1 | - |
| Human Coxsackievirus B3 | - |
적응증 및 용법
용량 및 투여 방법
경고 및 주의 사항
WARNINGS: If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.
Frequently Asked Questions
INDICATIONS: May temporarily relieve symptoms such as headaches.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
DIRECTIONS: Adults and children 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.
WARNINGS: If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.
Coxsackie Nosode A3, A4, A5, A7, B1, B3, B5 is available over the counter (OTC) without a prescription.
Similar Tablet Products
Browse all Tablet products →References & Data Sources
- • DailyMed — Coxsackie Nosode A3, A4, A5, A7, B1, B3, B5 drug label (National Library of Medicine)
- • openFDA — Coxsackie Nosode A3, A4, A5, A7, B1, B3, B5 label data (U.S. Food & Drug Administration)
- • NDC Directory — Coxsackie Nosode A3, A4, A5, A7, B1, B3, B5 (FDA National Drug Code)
의료 면책 조항
이 페이지의 정보는 교육 목적으로만 제공되며, 전문적인 의학적 조언, 진단 또는 치료를 대체하는 용도로 사용해서는 안 됩니다.
의학적 상태나 의약품에 관한 질문이 있으시면 반드시 의사 또는 자격을 갖춘 의료 전문가에게 조언을 구하시기 바랍니다.
데이터 출처: DailyMed (NLM), openFDA, MFDS